A cutting-edge project to test “fusion blanket” technologies is taking shape, with the Idaho National Laboratory (INL) ...

The instrument is used for advanced immunohistochemistry, in situ hybridization, and fluorescence in situ hybridization applications.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Centers for Medicare & Medicaid ...

A local cancer testing and research lab has purchased Pathline in New Jersey. Terms of the deal were not disclosed.

The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.

Guardant Health said the CMS determination confirms that the Shield test meets the criteria for ADLT status, which is reserved for innovative products that provide novel clinical information that ...

You can test for lactose intolerance at home or through a provider. This article covers testing accuracy and helps you ...

Guardant Health ( NASDAQ: GH) traded higher in the morning hours on Tuesday after the company announced that the U.S. Centers ...

Nebius Group Nebius Academy and Stevens Institute of Technology launch lab to explore how AI can advance math research and ...

On Monday, WSU announced Lynn and Sherry Nichols have given $1 million to the university to launch the fundraising campaign ...

Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that ...

Guardant Health (GH) announced the Centers for Medicare & Medicaid Services CMS has approved Advanced Diagnostic Laboratory Test ADLT ...